☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Five Indications
Celltrion's Remsima SC (infliximab- CT-P13) Receives the EC's MAA for Additional Five Indications
July 27, 2020
Celltrion's Remsima SC (biosimilar- infliximab) Receives CHMP's Positive Opinion for an Additional Five Indications Including Infl...
June 30, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.